| 1 |
27624579 | Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus. | 2017 Jan |
1 |
| 2 |
22898766 | Degradation of islet amyloid polypeptide by neprilysin. | 2012 Nov |
2 |
| 3 |
19146426 | Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin. | 2009 Mar 24 |
1 |
| 4 |
17902185 | Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives. | 2007 |
1 |
| 5 |
12609749 | Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. | 2003 Mar 28 |
1 |
| 6 |
10866048 | Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. | 2000 Jun |
2 |
| 7 |
7479680 | Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans. | 1995 Aug |
1 |
| 8 |
1787825 | Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus. | 1991 Nov |
1 |
| 9 |
7030721 | Effect of islet-activating protein (IAP) upon insulin secretion from human pancreatic islets. | 1981 Apr |
1 |